Analysis of the RNA helicase a gene in human lung cancer

Oncology Reports

Volumn 11, Issue 1, 2004, Pages 253-258

  Wei, Xiao ^a,b   Pacyna Gengelbach, Manuela ^a   Schlüns, Karsten ^a   An, Qian ^a,c   Gao, Yanning ^b   Cheng, Shujun ^b   Petersen, Iver ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b CANCER HOSPITAL   (China)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

CGH; Lung cancer; Overexpression; Quantitative PCR; RHA; SSH

Indexed keywords

AUTOANTIGEN; DEAD BOX PROTEIN; DHX9 PROTEIN, HUMAN; RNA; RNA HELICASE; TUMOR PROTEIN;

ARTICLE; CELL LINE; COMPARATIVE STUDY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; METHODOLOGY; NORTHERN BLOTTING; NUCLEIC ACID HYBRIDIZATION; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

AUTOANTIGENS; BLOTTING, NORTHERN; CELL LINE; CELL LINE, TUMOR; DEAD-BOX RNA HELICASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; NEOPLASM PROTEINS; NUCLEIC ACID HYBRIDIZATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA HELICASES; RNA, NEOPLASM;

EID: 3042674914     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.1.253     Document Type: Article

References (31)

1. Ihde DC: Chemotherapy of lung cancer. N Engl J Med 327: 1434-1441, 1992.
2. Hirsch FR, Franklin WA, Gazdar AF and Bunn PA: Early dectection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin Cancer Res 7: 5-22, 2001. (Pubitemid 32110200)
3. Cheng SJ, Gao Y, Dong X, Lu Y, An Q, Tong T and Wang Y: Molecular and cytogenetic alterations in early stage of carcinogenesis of human lung. Cancer Lett 162: S5-S10, 2001.
4. Petersen I and Petersen S: Toward a genetic-based classification of human lung cancer. Anal Cell Pathol 22: 111-121, 2001. (Pubitemid 32673745)
5. Braithwaite KL and Rabbitts PH: Multi-step evolution of lung cancer. Cancer Biol 9: 255-265, 1999. (Pubitemid 29429990)
6. ink4a is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci USA 95: 11891-11896, 1998.
7. Wong DJ, Foster SA, Galloway DA and Reid BJ: Progressive region-specific de novo methylation of the p16 CpG island in primary human mammary epithelial cell strains during escape from M0 growth arrest. Mol Cell Biol 19: 5642-5651, 1999. (Pubitemid 29339921)
8. Nuovo GJ, Plaia TW, Belinsky SA, Baylin SB and Herman JG: In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. Proc Natl Acad Sci USA 96: 12754-12759, 1999. (Pubitemid 29513575)
9. Petersen S, Rudolf J, Bockmühl U, Deutschmann N, Dietel M and Petersen I: Analysis of the DMBT1 gene in carcinomas of the respiratory tract. Int J Cancer 88: 71-76, 2000.
10. An Q, Pacyna-Gengelbach M, Schlüns K, Deutschmann N, Guo S, Gao Y, Zhang JJ, Cheng SJ and Petersen I: Identification of differentially expressed genes in immortalized human bronchial epithelial cell line as a model for in vitro study of lung carcinogenesis. Int J Cancer 103: 194-204, 2003. (Pubitemid 35461511)
11. Petersen S, Aninat-Meyer M, Schlüns K, Gellert K, Dietel M and Petersen I: Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung. Br J Cancer 82: 65-73, 2000. (Pubitemid 30008960)
12. Goeze A, Schlüns K, Wolf G, Thäsler Z, Petersen S and Petersen I: Chromosomal imbalances of primary and metastatic lung adenocarcinomas. J Pathol 196: 8-16, 2002.
13. Myöhänen S and Baylin SB: Sequence-specific DNA binding activity of RNA helicase A to the p16ink4a promoter. J Biol Chem 276: 1634-1642, 2001. (Pubitemid 32098014)
14. Tanner NK and Linder P: DexD/H box RNA helicases: from generic motors to specific dissociation functions. Mol Cell 8: 251-162, 2001.
15. Zhang S, Buder K, Burkhardt C, Schlott B, Görlach M and Crosse F: Nuclear DNA helicase II/RNA helicase A binds to filamentous actin. J Biol Chem 277: 843-853, 2002. (Pubitemid 34952126)
16. Niklinski J, Niklinska W, Laudanski J, Chyczewska E and Chyczewski L: Prognostic molecular markers in non-small cell lung cancer. Lung Cancer 34: S53-S58, 2001. (Pubitemid 33101846)
17. Beasley MB, Lantuejoul S, Abbondanzo S, Chu W, Hasleton PS, Path F, Travis WD and Brambilla E: The p16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung. Hum Pathol 34: 136-142, 2003. (Pubitemid 36258804)
18. Petersen S, Heckert C, Rudolf J, Schlüns K, Tchernitsa OI, Schäfer R, Dietel M and Petersen I: Gene expression profiling of advance lung cancer. Int J Cancer 86: 512-517, 2000. (Pubitemid 30249731)
19. Chen Y, Petersen S, Pacyna-Gengelbach M, Pietas A and Petersen I: Identification of a novel homeobox-containing gene, LAGY, which is downregulated in lung cancer. Oncology 64: 450-458, 2003. (Pubitemid 36682961)
20. Overbergh L, Valckx D, Waer M and Mathieu C: Quantification of murine cytokine mRNAs using time quantitative reverse transcriptase PCR. Cytokine 11: 305-312, 1999. (Pubitemid 29213178)
21. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R and Mathieu C: An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25: 386-401, 2001. (Pubitemid 34164011)
22. Aratani S, Fujii R, Oishi T, Fujita H, Amano T, Ohshima T, Hagiwara M, Fukamizu A and Nakajima T: Dual roles of RNA helicase A in CREB-dependent transcription. Mol Cell Biol 21: 4460-4469, 2001. (Pubitemid 32588231)
23. Lee CG, Soares VC, Newberger C, Manova K, Lacy E and Hurwitz J: RNA helicase A is essential for normal gastrulation. Proc Natl Acad Sci USA 95: 13709-13713, 1998. (Pubitemid 28523037)
24. Sekido Y, Fong KM and Minna JD: Progress in understanding the molecular pathogenesis of human lung cancer. Biochim Biophys Acta 1378: F21-F59, 1998. (Pubitemid 28381125)
25. ink4a inactivation in non small-cell lung cancers. Oncogene 16: 497-504, 1998.
26. Zöchbauer-Müller S, Fong KM, Geradts J Gazdar AF and Minna JD: Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res 61: 249-255, 2001. (Pubitemid 32095725)
27. ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers. Clin Cancer Res 5: 791-800, 1999.
28. ink4a expression in non-small cell lung carcinoma. Cancer 80: 389-395, 1997.
29. Brambilla E, Moro D, Gazzeri S and Brambilla C: Alterations of expression of Rb, p16(ink4a) and cyclin D1 in non-small cell lung carcinoma and their clinical significance. J Pathol 188: 341-343, 1999.
30. Fujii R, Okamoto M, Aratani S, Oishi T, Ohshima T, Taira K, Baaba M, Fukamizu A and Nakajima T: A role of RNA helicase A in cis-acting transactivation response element-mediated transcriptional regulation of human immunodeficiency virus type 1. J Biol Chem 276: 5445-5451, 2001.
31. Kaye FJ: RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer. Oncogene 21: 6908-6914, 2002.